MAGNESIUM SALICYLATE

MAGNESIUM SALICYLATE was reported 606 times

MAGNESIUM SALICYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARCINOID TUMOUR IN THE LARGE INTESTINE 1 0.0526
1 UROBILINOGEN URINE 1 0.0370
2 CORTISOL DEFICIENCY 1 0.0345
3 MYCOSIS FUNGOIDES STAGE IV 1 0.0345
4 POST-TRAUMATIC AMNESTIC DISORDER 1 0.0154
5 CORYNEBACTERIUM TEST POSITIVE 1 0.0141
6 COMPLEMENT FACTOR INCREASED 1 0.0119
7 PERICORONITIS 1 0.0110
8 CREATINE PHOSPHOKINASE DECREASED 1 0.0105
9 ABSCESS STERILE 1 0.0068
10 RADIATION PROCTITIS 1 0.0054
11 COMPLEMENT FACTOR C4 DECREASED 1 0.0052
12 METASTASES TO EYE 1 0.0046
13 METATARSALGIA 1 0.0042
14 COMPLEMENT FACTOR C3 DECREASED 1 0.0041
15 SKULL FRACTURED BASE 1 0.0040
16 CATHETER SITE CELLULITIS 1 0.0034
17 DOUBLE STRANDED DNA ANTIBODY POSITIVE 1 0.0031
18 PNEUMOCEPHALUS 1 0.0030
19 PRODUCT QUALITY ISSUE 379 0.0028
20 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
21 LENTICULAR OPACITIES 1 0.0023
22 VULVOVAGINAL INFLAMMATION 1 0.0022
23 T-LYMPHOCYTE COUNT DECREASED 1 0.0015
24 BRAIN CONTUSION 1 0.0014
25 AMINO ACID LEVEL INCREASED 1 0.0013
26 KETONURIA 1 0.0012
27 PENILE HAEMORRHAGE 1 0.0012
28 HYPOPITUITARISM 2 0.0011
29 PRODUCT SHAPE ISSUE 1 0.0011
30 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
31 BLADDER DYSFUNCTION 1 0.0010
32 GASTROINTESTINAL VIRAL INFECTION 1 0.0010
33 EXOPHTHALMOS 2 0.0009
34 JC POLYOMAVIRUS TEST POSITIVE 1 0.0009
35 BLADDER DISCOMFORT 1 0.0008
36 SLOW RESPONSE TO STIMULI 1 0.0008
37 ANION GAP INCREASED 1 0.0007
38 IMMUNOGLOBULINS DECREASED 1 0.0007
39 MENINGITIS BACTERIAL 1 0.0007
40 SKIN STRIAE 1 0.0007
41 URINE KETONE BODY PRESENT 1 0.0006
42 STUPOR 2 0.0006
43 COSTOCHONDRITIS 1 0.0006
44 THYROIDECTOMY 1 0.0006
45 CONJUNCTIVAL HYPERAEMIA 2 0.0006
46 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
47 INTENTIONAL MISUSE 1 0.0005
48 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
49 BREAST DISORDER 1 0.0005
50 SELF-MEDICATION 2 0.0005
51 HALLUCINATIONS, MIXED 2 0.0005
52 JAW FRACTURE 1 0.0005
53 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
54 METASTASES TO BONE 7 0.0004
55 VITILIGO 1 0.0004
56 URINARY HESITATION 1 0.0004
57 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
58 PROTEIN TOTAL INCREASED 1 0.0004
59 ALCOHOL POISONING 1 0.0004
60 ABDOMINAL RIGIDITY 1 0.0004
61 FAECALOMA 2 0.0004
62 PANCREATIC CARCINOMA METASTATIC 1 0.0004
63 ESCHERICHIA SEPSIS 1 0.0003
64 CREPITATIONS 1 0.0003
65 RESPIRATORY RATE DECREASED 1 0.0003
66 PRODUCT USE COMPLAINT 5 0.0003
67 DRUG INEFFECTIVE 416 0.0003
68 LYME DISEASE 1 0.0003
69 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
70 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
71 TYPE I HYPERSENSITIVITY 1 0.0003
72 FRUSTRATION 1 0.0003
73 AMYLASE INCREASED 1 0.0003
74 THROAT CLEARING 1 0.0003
75 PROTEIN TOTAL DECREASED 1 0.0003
76 SENSATION OF HEAVINESS 1 0.0003
77 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
78 FOREIGN BODY 1 0.0002
79 ENURESIS 1 0.0002
80 PERIPHERAL ISCHAEMIA 1 0.0002
81 INCREASED TENDENCY TO BRUISE 2 0.0002
82 SINUS TACHYCARDIA 3 0.0002
83 EXPIRED DRUG ADMINISTERED 1 0.0002
84 PROTEIN URINE PRESENT 1 0.0002
85 PRODUCT PHYSICAL ISSUE 4 0.0002
86 PARTIAL SEIZURES 1 0.0002
87 PRODUCT SIZE ISSUE 1 0.0002
88 GINGIVITIS 1 0.0002
89 JAW DISORDER 1 0.0002
90 CHOKING SENSATION 1 0.0002
91 MACULAR OEDEMA 1 0.0002
92 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
93 VULVOVAGINAL BURNING SENSATION 1 0.0002
94 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
95 EXPIRED PRODUCT ADMINISTERED 5 0.0002
96 PRODUCT ADMINISTRATION ERROR 3 0.0001
97 METASTASES TO LYMPH NODES 1 0.0001
98 DISEASE RECURRENCE 7 0.0001
99 LYMPHOEDEMA 1 0.0001
100 LARGE INTESTINE POLYP 1 0.0001
101 DEFAECATION URGENCY 1 0.0001
102 RETINAL HAEMORRHAGE 1 0.0001
103 BRONCHOSPASM 2 0.0001
104 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
105 GASTROENTERITIS 2 0.0001
106 ORAL DISORDER 1 0.0001
107 KETOACIDOSIS 1 0.0001
108 CHROMATURIA 3 0.0001
109 TENDON PAIN 1 0.0001
110 BLOOD COUNT ABNORMAL 2 0.0001
111 BOWEL MOVEMENT IRREGULARITY 1 0.0001
112 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
113 CYANOSIS 2 0.0001
114 DRUG SCREEN POSITIVE 1 0.0001
115 BLOOD ALBUMIN DECREASED 1 0.0001
116 MIOSIS 1 0.0001
117 BLOOD MAGNESIUM DECREASED 1 0.0001
118 ORTHOSTATIC HYPOTENSION 2 0.0001
119 PALLOR 3 0.0001
120 TINNITUS 5 0.0001
121 HEPATIC ENCEPHALOPATHY 1 0.0001
122 BLOOD URINE PRESENT 2 0.0001
123 PRODUCT PACKAGING ISSUE 1 0.0001
124 RED BLOOD CELL COUNT DECREASED 3 0.0001
125 MOTOR DYSFUNCTION 1 0.0001
126 INCONTINENCE 1 0.0001
127 BREAST CANCER METASTATIC 1 0.0001
128 RECTAL HAEMORRHAGE 4 0.0001
129 SKIN LACERATION 1 0.0001
130 ASPIRATION 1 0.0001
131 SKIN INFECTION 1 0.0001
132 BLOOD CALCIUM DECREASED 1 0.0001
133 IMPAIRED DRIVING ABILITY 1 0.0001
134 MICTURITION URGENCY 1 0.0001
135 INTERNAL HAEMORRHAGE 1 0.0001
136 BLOOD IRON DECREASED 1 0.0001
137 NOCTURIA 1 0.0001
138 MUSCLE SPASTICITY 1 0.0001
139 HYPERCALCAEMIA 1 0.0001
140 DERMATITIS ALLERGIC 1 0.0001
141 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
142 ORAL CANDIDIASIS 1 0.0001
143 TOOTH INFECTION 1 0.0001
144 DISORIENTATION 3 0.0001
145 PRODUCT TASTE ABNORMAL 1 0.0001
146 HUNGER 1 0.0001
147 DIALYSIS 1 0.0001
148 SUBDURAL HAEMATOMA 1 0.0001
149 UNDERDOSE 5 0.0001
150 SKIN HAEMORRHAGE 1 0.0001
151 HAEMORRHAGE INTRACRANIAL 1 0.0001
152 APHASIA 2 0.0001
153 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
154 OSTEOPENIA 1 0.0001
155 COGNITIVE DISORDER 3 0.0001
156 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
157 FACE OEDEMA 1 0.0001
158 DELIRIUM 2 0.0001
159 METASTASES TO LIVER 1 0.0001
160 COLD SWEAT 1 0.0001
161 ADVERSE DRUG REACTION 5 0.0001
162 RESTLESS LEGS SYNDROME 1 0.0001
163 HAEMATOCHEZIA 3 0.0001
164 ABDOMINAL DISCOMFORT 9 0.0001
165 HEPATIC CIRRHOSIS 1 0.0001
166 PROTEINURIA 1 0.0001
167 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
168 SLEEP APNOEA SYNDROME 1 0.0001
169 ACUTE RESPIRATORY FAILURE 1 0.0001
170 ERUCTATION 1 0.0001
171 KIDNEY INFECTION 1 0.0001
172 HAEMATOCRIT DECREASED 1 0.0001
173 CATARACT 3 0.0001
174 BLOOD PRESSURE ABNORMAL 1 0.0001
175 UPPER LIMB FRACTURE 1 0.0001
176 SPINAL FRACTURE 1 0.0000
177 TASTE DISORDER 1 0.0000
178 VERTIGO 3 0.0000
179 OSTEOPOROSIS 2 0.0000
180 POLLAKIURIA 2 0.0000
181 ROAD TRAFFIC ACCIDENT 2 0.0000
182 TOXICITY TO VARIOUS AGENTS 8 0.0000
183 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
184 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
185 STEVENS-JOHNSON SYNDROME 1 0.0000
186 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
187 DIABETIC KETOACIDOSIS 1 0.0000
188 LOCALISED INFECTION 1 0.0000
189 ENCEPHALOPATHY 1 0.0000
190 HEART RATE INCREASED 4 0.0000
191 VISUAL IMPAIRMENT 5 0.0000
192 AGEUSIA 1 0.0000
193 PNEUMONIA ASPIRATION 1 0.0000
194 CELLULITIS 2 0.0000
195 HAEMATEMESIS 1 0.0000
196 CARDIOVASCULAR DISORDER 1 0.0000
197 HEPATITIS 1 0.0000
198 HAEMOGLOBIN DECREASED 4 0.0000
199 ILLNESS 4 0.0000
200 SKIN ULCER 1 0.0000
201 PANCREATITIS 2 0.0000
202 BLOOD BILIRUBIN INCREASED 1 0.0000
203 ANAPHYLACTIC REACTION 2 0.0000
204 MENTAL STATUS CHANGES 1 0.0000
205 FEELING COLD 1 0.0000
206 WOUND 1 0.0000
207 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
208 URINARY TRACT INFECTION 6 0.0000
209 ANGINA PECTORIS 1 0.0000
210 HERPES ZOSTER 2 0.0000
211 EYE IRRITATION 2 0.0000
212 BALANCE DISORDER 3 0.0000
213 BONE PAIN 2 0.0000
214 SURGERY 2 0.0000
215 ASCITES 1 0.0000
216 ABDOMINAL PAIN UPPER 7 0.0000
217 ACUTE MYOCARDIAL INFARCTION 1 0.0000
218 WHEEZING 2 0.0000
219 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
220 JOINT SWELLING 4 0.0000
221 THERAPEUTIC RESPONSE DECREASED 2 0.0000
222 OEDEMA PERIPHERAL 4 0.0000
223 LIMB DISCOMFORT 1 0.0000
224 PRODUCT USE ISSUE 6 0.0000
225 HEAD INJURY 1 0.0000
226 NEUROPATHY PERIPHERAL 3 0.0000
227 ANAEMIA 6 0.0000
228 CYSTITIS 1 0.0000
229 HYPOTHYROIDISM 1 0.0000
230 HIP FRACTURE 1 0.0000
231 DEEP VEIN THROMBOSIS 2 0.0000
232 EYE DISORDER 1 0.0000
233 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
234 BLOOD PRESSURE DECREASED 2 0.0000
235 SYNCOPE 3 0.0000
236 URINARY RETENTION 1 0.0000
237 GAIT INABILITY 1 0.0000
238 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
239 FLUSHING 3 0.0000
240 GASTRIC DISORDER 1 0.0000
241 HEART RATE DECREASED 1 0.0000
242 PLATELET COUNT DECREASED 3 0.0000
243 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
244 CONSTIPATION 6 0.0000
245 PANIC ATTACK 1 0.0000
246 ACCIDENTAL OVERDOSE 1 0.0000
247 RESTLESSNESS 1 0.0000
248 SEPSIS 3 0.0000
249 HEPATIC FUNCTION ABNORMAL 1 0.0000
250 EPISTAXIS 2 0.0000
251 DYSARTHRIA 1 0.0000
252 INTESTINAL OBSTRUCTION 1 0.0000
253 INCORRECT DOSE ADMINISTERED 6 0.0000
254 BLOOD PRESSURE INCREASED 4 0.0000
255 ACUTE KIDNEY INJURY 4 0.0000
256 GAIT DISTURBANCE 5 0.0000
257 PERIPHERAL SWELLING 4 0.0000
258 CHILLS 3 0.0000
259 EXTRA DOSE ADMINISTERED 1 0.0000
260 DYSKINESIA 1 0.0000
261 NEUTROPHIL COUNT DECREASED 1 0.0000
262 INFLUENZA LIKE ILLNESS 2 0.0000
263 LOSS OF CONSCIOUSNESS 3 0.0000
264 HYPOACUSIS 1 0.0000
265 COLITIS ULCERATIVE 1 0.0000
266 PULMONARY OEDEMA 1 0.0000
267 GASTROINTESTINAL DISORDER 2 0.0000
268 NEUTROPENIA 3 0.0000
269 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
270 HYPOKALAEMIA 1 0.0000
271 DECREASED APPETITE 5 0.0000
272 RENAL DISORDER 1 0.0000
273 COMA 1 0.0000
274 MIGRAINE 2 0.0000
275 BLOOD GLUCOSE DECREASED 1 0.0000
276 DRUG INTOLERANCE 2 0.0000
277 INFLAMMATION 1 0.0000
278 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
279 BRADYCARDIA 1 0.0000
280 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
281 DRUG EFFECT DECREASED 1 0.0000
282 OEDEMA 1 0.0000
283 TREATMENT NONCOMPLIANCE 1 0.0000
284 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
285 ARTHROPATHY 1 0.0000
286 FATIGUE 14 0.0000
287 HYPONATRAEMIA 1 0.0000
288 CEREBROVASCULAR ACCIDENT 3 0.0000
289 RHEUMATOID ARTHRITIS 2 0.0000
290 CONVULSION 1 0.0000
291 LETHARGY 1 0.0000
292 BACK PAIN 4 0.0000
293 DIARRHOEA 11 0.0000
294 BLADDER CANCER 1 0.0000
295 STOMATITIS 1 0.0000
296 ILL-DEFINED DISORDER 1 0.0000
297 MUSCLE SPASMS 3 0.0000
298 FEELING HOT 1 0.0000
299 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
300 PAIN 10 0.0000
301 CHEST PAIN 3 0.0000
302 HYPERSENSITIVITY 3 0.0000
303 RASH 7 0.0000
304 DIZZINESS 8 0.0000
305 ASTHENIA 6 0.0000
306 HYPERHIDROSIS 2 0.0000
307 AMNESIA 1 0.0000
308 INFUSION RELATED REACTION 1 0.0000
309 FEBRILE NEUTROPENIA 1 0.0000
310 INSOMNIA 4 0.0000
311 DEHYDRATION 2 0.0000
312 HYPOTENSION 3 0.0000
313 SOMNOLENCE 3 0.0000
314 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
315 MEMORY IMPAIRMENT 2 0.0000
316 PYREXIA 5 0.0000
317 SLEEP DISORDER 1 0.0000
318 HYPERTENSION 3 0.0000
319 INFECTION 2 0.0000
320 OFF LABEL USE 12 0.0000
321 MALAISE 6 0.0000
322 PAIN IN EXTREMITY 4 0.0000
323 BRONCHITIS 1 0.0000
324 DYSGEUSIA 1 0.0000
325 HYPOAESTHESIA 2 0.0000
326 ACNE 1 0.0000
327 DEPRESSION 3 0.0000
328 CHRONIC KIDNEY DISEASE 1 0.0000
329 CONDITION AGGRAVATED 4 0.0000
330 CARDIAC FAILURE 1 0.0000
331 CONFUSIONAL STATE 2 0.0000
332 DRY MOUTH 1 0.0000
333 CARDIAC ARREST 1 0.0000
334 TREATMENT FAILURE 1 0.0000
335 FALL 4 0.0000
336 COMPLETED SUICIDE 1 0.0000
337 MYALGIA 2 0.0000
338 NAUSEA 9 0.0000
339 TACHYCARDIA 1 0.0000
340 HEADACHE 7 0.0000
341 NO ADVERSE EVENT 2 0.0000
342 SUICIDAL IDEATION 1 0.0000
343 ADVERSE EVENT 1 0.0000
344 COUGH 3 0.0000
345 CARDIAC DISORDER 1 0.0000
346 BLOOD GLUCOSE INCREASED 2 0.0000
347 DYSPHAGIA 1 0.0000
348 PRURITUS 4 0.0000
349 CONTUSION 1 0.0000
350 ATRIAL FIBRILLATION 1 0.0000
351 DYSPEPSIA 1 0.0000
352 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
353 SINUSITIS 1 0.0000
354 HAEMORRHAGE 1 0.0000
355 OVERDOSE 2 0.0000
356 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
357 WEIGHT INCREASED 2 0.0000
358 MUSCULAR WEAKNESS 1 0.0000
359 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
360 VOMITING 4 0.0000
361 DISEASE PROGRESSION 1 0.0000
362 RENAL FAILURE 1 0.0000
363 DRY SKIN 1 0.0000
364 VISION BLURRED 1 0.0000
365 ARTHRALGIA 3 0.0000
366 WEIGHT DECREASED 2 0.0000
367 ANXIETY 2 0.0000
368 DEATH 6 0.0000
369 PRODUCT DOSE OMISSION ISSUE 2 0.0000
370 PARAESTHESIA 1 0.0000
371 DRUG INTERACTION 1 0.0000
372 PNEUMONIA 2 0.0000
373 MYOCARDIAL INFARCTION 1 0.0000
374 NASOPHARYNGITIS 1 0.0000
375 DYSPNOEA 3 0.0000
376 ABDOMINAL PAIN 1 0.0000
377 FEELING ABNORMAL 1 0.0000